UTHR UNITED THERAPEUTICS Earnings and EPS analysis

EPS in 2026 (TTM): $28.57

Last Report Period Date: Sep 30, 2026

As of November 2026, according to UNITED THERAPEUTICS's latest financial report, the company's current EPS (TTM) is $28.57. In 2025, the company recorded an earnings per share (EPS) of $30.13, which represents an increase compared to its EPS of $26.44 in 2024. UNITED THERAPEUTICS's earnings per share for the quarterly report ending on Sep 30, 2026 was $6.06.

The annual EPS in 2025 was $30.13, an increase of 14% from $26.44 in 2024. For the quarter ending Sep 30, 2026, the EPS was $6.06, showing a 21.6% decrease from the same quarter last year. The trailing twelve months (TTM) EPS as of September 2026 is $28.57. In 2024, the annual EPS was $26.44, showing an increase of 25.7% from 2023.

UNITED THERAPEUTICS has recorded a decrease in EPS of 21.6% over the last 12 months (YoY, quarterly). For the last three years, UTHR recorded an average annual EPS growth rate of 23.5%. UNITED THERAPEUTICS had an average annual EPS growth rate of 20.9% over the last 5 years. Across the last decade, UTHR had an average annual EPS growth of 7.8%.